📣Proud to announce our Practical Medical Oncology Textbook 📘 📕 a great collaboration 🇺🇸🇮🇹🇧🇪Didactically structured with a wealth of figures, schemes, clinical cases and expert tips @antoniorusso_pa @unipait @IcahnMountSinai @UAntwerpen @myESMO @ASCO link.springer.com/book/10.1007/9…
Christian Rolfo
9,786 posts
Director Division of Medical Oncology. Assoc Director Early Phase Clinical Trials The James Comprehensive Cancer Center. Prof. The OSU.Liquid Biopsy T/RT my own
- Very honored to join from August @OSUCCC_James as Director Division of Medical Oncology and Associate Director for Early Phase Clinical Trials in @OhioState ’s Comprehensive Cancer Center a leading institution in oncology care and research with an outstanding team!We're thrilled to announce that Christian Rolfo, MD, PhD, will join The James team as director of our Division of Medical #Oncology. Welcome to #BuckeyeNation Dr. Rolfo! cancer.osu.edu/news/ohio-stat…
- We started #WCLC22 with the @IASLC Academy workshop! A great initiative to support career development. Congrats to the awardees and thanks to the faculty! @JPatelMD @marinagarassino @JackWestMD @danieltanmd @StephenVLiu @karenkellymd @HwakeleeMD @RManochakian @Piuchagarrido
- 📣Our paper on NTRK1 Fusions identified by non-invasive plasma next-generation sequencing (NGS) across 9 cancer types it’s online @alexdrilon @Al3ssandroRusso @DavidHongMD @drgandara @JessicaJLinMD @CarolineMccoach @ntrkconnectinfo @NTRKers nature.com/articles/s4141…
- Today family picture with some of the 87 amazing faculty of our Division of Medical Oncology at The James CCC. Very honored to be part and lead this incredible team! @OhioStateMedOnc @OSUCCC_James @OhioStateMed
- Small cell lung cancer: Novel treatments beyond immunotherapy, a great collaboration with @elisagiovan @MarcelloTiseo and team for this overview in new biomarkers at SCLC sciencedirect.com/science/articl…! @OncoAlert @isliquidbiopsy @lcsmchat @ELS_Oncology
- I’m leaving @UMmedschool after 3 years of a great experience! Thanks to patients, team and staff for their kindness and support. A privilege to work in this great institution, the first public school of medicine in 🇺🇸. I’ll bring you all in my heart! @RaneeMehra @KatherineScilla
- of the #10yearchallenge I choose these two photos that shown the radical change in the landscape of lung cancer treatment in the last 10 years. amazing!! #LCSM let's go for more!
- Very honored to serve as Chair of the Educational Committee at @IASLC 2021-2023 and continue to collaborate with the upcoming chair @PranshuMohindra & an extraordinary group of members from around the world. Thanks @IASLC for the support! @karenkellymd @HwakeleeMD #WCLC23
- I’m deeply honored to receive the distinction of Doctor Honoris Causa from the prestigious University of Buenos Aires. My heartfelt thanks to @UBAonline for this meaningful recognition and for its enduring commitment to academic excellence & global collaboration @OhioStateMedOncThe Superior Council of the University of Buenos Aires (UBA) held a session where it was decided to grant @ChristianRolfo the title of "Doctor Honoris Causa”. This prestigious degree is a direct result of his unwavering and selfless support for our University.
- The largest NSCLC dataset analyzed for biomarker distribution across histologies, sufficient enough prevalence across LUAD and ASC to be included in WHO for lung tumors, and provides reassurance that NOS, LCC and sarcomatoid cases must be considered for biomarker workup #ASCO24
- Great collaboration with @AndresFCardonaZ and team in this paper giving insights on Bispecific Antibodies in Cancer Immunotherapy: A Novel Response an Old Question mdpi.com/1673784 #mdpipharmaceutics @Al3ssandroRusso @lucia_zatarain @ogarrieta @ddemiguelperez @OncoAlert
- NTRK1 Fusions identified by non-invasive plasma next-generation sequencing (NGS) across 9 cancer types @drgandara @alexdrilon @Al3ssandroRusso @isliquidbiopsy @MSHSThoracicOnc @oncoalert @BrJCancer nature.com/articles/s4141…
- Our new paper How I treat ALK-positive non-small cell lung cancer | published today in ESMO Open esmoopen.bmj.com/content/4/Supp… @ESMO_Open @UMGCCC @UMmedschool @alk_fusion #LCSM #oncoalert


















